Non-alcoholic fatty liver disease epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
==Epidemiology== | ==Epidemiology== | ||
* NAFLD is associated with visceral obesity and diabetes. | |||
NAFLD is associated with visceral obesity and diabetes. It has reflected the epidemiologic direction of weight problems inside the US and is detected in 73–90% of obese people on biopsy. | * It has reflected the epidemiologic direction of weight problems inside the US and is detected in 73–90% of obese people on biopsy. | ||
* About 1/3 of america population are expected to have NAFL. with the aid of maximum estimates, NASH contains about 15% of all NAFLD and 3–5% of the american populace. | |||
* Hospitalizations for NAFLD have elevated by means of 97%.<ref name="pmid28507929">{{cite journal |vauthors=Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J |title=Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies |journal=J Clin Transl Hepatol |volume=5 |issue=1 |pages=67–75 |year=2017 |pmid=28507929 |pmc=5411359 |doi=10.14218/JCTH.2016.00061 |url=}}</ref> | |||
===Prevalance=== | ===Prevalance=== | ||
* As the prevalence of fatty liver ailment increases, clinicians can have greater equipment at hand for control of this condition. We conclude the horizon is vibrant for sufferers and docs who address NAFLD.<ref name="pmid285079292">{{cite journal |vauthors=Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J |title=Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies |journal=J Clin Transl Hepatol |volume=5 |issue=1 |pages=67–75 |year=2017 |pmid=28507929 |pmc=5411359 |doi=10.14218/JCTH.2016.00061 |url=}}</ref> | * As the prevalence of fatty liver ailment increases, clinicians can have greater equipment at hand for control of this condition. | ||
* We conclude the horizon is vibrant for sufferers and docs who address NAFLD.<ref name="pmid285079292">{{cite journal |vauthors=Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J |title=Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies |journal=J Clin Transl Hepatol |volume=5 |issue=1 |pages=67–75 |year=2017 |pmid=28507929 |pmc=5411359 |doi=10.14218/JCTH.2016.00061 |url=}}</ref> | |||
===Ethinicity=== | ===Ethinicity=== | ||
As a part of the Dallas Heart Study,<ref name="Browning">Browning et al. Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity. Hepatology 2004;40:1387-1395.</ref> 2,240 patients - 1,105 [[african-americans]], 401 [[hispanics]] and 734 [[caucasians]] - received abdominal MRI's from which we can infer the presence of [[steatosis]]. [[Hepatic]] [[steatosis]] was found in 45% of [[hispanics]] (both men and women), 33% of caucasians (42% of men, 24% of women) and 24% of african-american (23% of men, 24% of women). This pattern may hold true in children as well. In a San Diego study of 742 consecutive [[autopsy|autopsies]] of children victims of trauma over 10 years, [[fatty live]]r was found in 9.6% of all children, 38% of the [[obese]], 12% of hispanics, 10% of asians, 8.6% of caucasians and 1.5% of african-americans.<ref name=" | * As a part of the Dallas Heart Study,<ref name="Browning">Browning et al. Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity. Hepatology 2004;40:1387-1395.</ref> 2,240 patients - 1,105 [[african-americans]], 401 [[hispanics]] and 734 [[caucasians]] - received abdominal MRI's from which we can infer the presence of [[steatosis]]. | ||
* [[Hepatic]] [[steatosis]] was found in 45% of [[hispanics]] (both men and women), 33% of caucasians (42% of men, 24% of women) and 24% of african-american (23% of men, 24% of women). | |||
* This pattern may hold true in children as well. In a San Diego study of 742 consecutive [[autopsy|autopsies]] of children victims of trauma over 10 years, [[fatty live]]r was found in 9.6% of all children, 38% of the [[obese]], 12% of hispanics, 10% of asians, 8.6% of caucasians and 1.5% of african-americans.<ref name="pmid24868321">{{cite journal |vauthors=Pan JJ, Fallon MB |title=Gender and racial differences in nonalcoholic fatty liver disease |journal=World J Hepatol |volume=6 |issue=5 |pages=274–83 |year=2014 |pmid=24868321 |pmc=4033285 |doi=10.4254/wjh.v6.i5.274 |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 16:12, 8 December 2017
|
Non-Alcoholic Fatty Liver Disease Microchapters |
|
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case studies |
|
Non-alcoholic fatty liver disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease epidemiology and demographics |
|
FDA on Non-alcoholic fatty liver disease epidemiology and demographics |
|
CDC on Non-alcoholic fatty liver disease epidemiology and demographics |
|
Non-alcoholic fatty liver disease epidemiology and demographics in the news |
|
Blogs on Non-alcoholic fatty liver disease epidemiology and demographics |
|
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Editor in Chief: Elliot Tapper, M.D., Beth Israel Deaconess Medical Center, C. Michael Gibson, M.S., M.D. [1]
Overview
In the third National Health and Nutrition Examination Survey (NHANES III), the peak prevalence of NAFLD in men occurred in the fourth decade and in the sixth decade for women.NAFLD is associated with visceral obesity and diabetes. It has mirrored the epidemiologic course of obesity in the US and is detected in 73–90% of obese individuals on biopsy. Approximately 1/3 of the usa population are estimated to have NAFL. Through most estimates, NASH accommodates approximately 15% of all NAFLD and 3–5% of the american populace.
Epidemiology and Demographics
Epidemiology
- NAFLD is associated with visceral obesity and diabetes.
- It has reflected the epidemiologic direction of weight problems inside the US and is detected in 73–90% of obese people on biopsy.
- About 1/3 of america population are expected to have NAFL. with the aid of maximum estimates, NASH contains about 15% of all NAFLD and 3–5% of the american populace.
- Hospitalizations for NAFLD have elevated by means of 97%.[1]
Prevalance
- As the prevalence of fatty liver ailment increases, clinicians can have greater equipment at hand for control of this condition.
- We conclude the horizon is vibrant for sufferers and docs who address NAFLD.[2]
Ethinicity
- As a part of the Dallas Heart Study,[3] 2,240 patients - 1,105 african-americans, 401 hispanics and 734 caucasians - received abdominal MRI's from which we can infer the presence of steatosis.
- Hepatic steatosis was found in 45% of hispanics (both men and women), 33% of caucasians (42% of men, 24% of women) and 24% of african-american (23% of men, 24% of women).
- This pattern may hold true in children as well. In a San Diego study of 742 consecutive autopsies of children victims of trauma over 10 years, fatty liver was found in 9.6% of all children, 38% of the obese, 12% of hispanics, 10% of asians, 8.6% of caucasians and 1.5% of african-americans.[4]
References
- ↑ Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J (2017). "Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies". J Clin Transl Hepatol. 5 (1): 67–75. doi:10.14218/JCTH.2016.00061. PMC 5411359. PMID 28507929.
- ↑ Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J (2017). "Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies". J Clin Transl Hepatol. 5 (1): 67–75. doi:10.14218/JCTH.2016.00061. PMC 5411359. PMID 28507929.
- ↑ Browning et al. Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity. Hepatology 2004;40:1387-1395.
- ↑ Pan JJ, Fallon MB (2014). "Gender and racial differences in nonalcoholic fatty liver disease". World J Hepatol. 6 (5): 274–83. doi:10.4254/wjh.v6.i5.274. PMC 4033285. PMID 24868321.